Vaccination in pregnancy. Consensus document of the CAV-AEP and the SEGO
During pregnancy, physiological changes in the immune response make pregnant women more susceptible to serious infection, increasing the risk for the mother as well as the foetus, newborn and infant. All women should be correctly and fully vaccinated as they enter their reproductive years, especiall...
Gespeichert in:
Veröffentlicht in: | Anales de Pediatría 2024-04, Vol.100 (4), p.268-274 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 274 |
---|---|
container_issue | 4 |
container_start_page | 268 |
container_title | Anales de Pediatría |
container_volume | 100 |
creator | Álvarez Aldeán, Javier José Álvarez García, Francisco de la Calle Fernández-Miranda, Maria Figueras Falcón, Tatiana Iofrío de Arce, Antonio López Rojano, Marta Rivero Calle, Irene Suy Franch, Anna |
description | During pregnancy, physiological changes in the immune response make pregnant women more susceptible to serious infection, increasing the risk for the mother as well as the foetus, newborn and infant. All women should be correctly and fully vaccinated as they enter their reproductive years, especially against diseases such as tetanus, hepatitis B, measles, rubella and varicella. In addition to the recommended vaccines, in risk situations, inactivated vaccines could be administered to women who were not correctly vaccinated before, while attenuated vaccines are contraindicated.
Despite the fact that vaccination during pregnancy is a very important preventive measure and the existing recommendations from public health authorities, scientific societies and health professionals, the vaccination coverage could clearly be improved, especially against influenza and SARS-CoV-2, so any health professional involved in the care of pregnant women should proactively recommend these vaccines.
The Spanish Association of Pediatrics (AEP), through its Advisory Committee on Vaccines, and the Spanish Society of Gynaecology and Obstetrics (SEGO) recommend vaccination against the following diseases during pregnancy: against influenza and COVID-19, in any trimester of pregnancy and during the postpartum period (up to 6 months post birth) in women not vaccinated during pregnancy; against pertussis, with the Tdap vaccine, between weeks 27 and 36 of gestation (in the CAV-AEP recommendations, preferably between weeks 27 and 28); and against RSV, with RSVPreF, between weeks 24 and 36 of gestation, preferably between weeks 32 and 36.
Durante el embarazo, los cambios fisiológicos en la respuesta inmunitaria favorecen que las gestantes sean más susceptibles a infecciones graves, tanto para ellas como para el feto, recién nacido y lactante. Todas las mujeres deberían entrar en el período reproductivo con su calendario vacunal correctamente cumplimentado, sobre todo en lo que respecta a enfermedades como tétanos, hepatitis B, sarampión, rubeola y varicela. Además de las vacunas recomendadas, en situaciones de riesgo las vacunas inactivadas podrían ser administradas en aquellas mujeres que no estuvieran correctamente inmunizadas con anterioridad, mientras que las atenuadas están contraindicadas.
A pesar de que la vacunación durante el embarazo es una medida preventiva muy importante, y de las recomendaciones de autoridades sanitarias, sociedades científicas y profesionales sanitarios, las |
doi_str_mv | 10.1016/j.anpede.2024.02.014 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3031662756</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2341287924001066</els_id><sourcerecordid>3031662756</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2024-3399a02ebd302252180fbb23a1ca05ab7d4d0cf2e24b615f48f0191e419286223</originalsourceid><addsrcrecordid>eNp9kE9Lw0AQxRdRbFG_gUiOXhJnZzdpchFKqX-gUEHtddnsTnRLu6nZROi3N7VVPHmaGfi9mTePsUsOCQee3SwT7TdkKUFAmQAmwOURG6KQPMZ8VBz_6QfsIoQlAKDgIpXZKRuIPM1SKUdD9rDQxjivW1f7yPlo09Cb195sk2hS-0A-dCGytenW5NuorqL2naLJeBGPp0-R9vZ7fp7ez8_ZSaVXgS4O9Yy93k1fJg_xbH7_OBnPYrOzGgtRFBqQSisAMUWeQ1WWKDQ3GlJdjqy0YCoklGXG00rmFfCCk-QF5hmiOGPX-72bpv7oKLRq7YKh1Up7qrugBAieZThKsx6Ve9Q0dQgNVWrTuLVutoqD2sWolmofo9p5U4Cqj7GXXR0udOWa7K_oJ7QeuN0D1P_56ahRwTjyhqxryLTK1u7_C18uk4HJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3031662756</pqid></control><display><type>article</type><title>Vaccination in pregnancy. Consensus document of the CAV-AEP and the SEGO</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Álvarez Aldeán, Javier ; José Álvarez García, Francisco ; de la Calle Fernández-Miranda, Maria ; Figueras Falcón, Tatiana ; Iofrío de Arce, Antonio ; López Rojano, Marta ; Rivero Calle, Irene ; Suy Franch, Anna</creator><creatorcontrib>Álvarez Aldeán, Javier ; José Álvarez García, Francisco ; de la Calle Fernández-Miranda, Maria ; Figueras Falcón, Tatiana ; Iofrío de Arce, Antonio ; López Rojano, Marta ; Rivero Calle, Irene ; Suy Franch, Anna</creatorcontrib><description>During pregnancy, physiological changes in the immune response make pregnant women more susceptible to serious infection, increasing the risk for the mother as well as the foetus, newborn and infant. All women should be correctly and fully vaccinated as they enter their reproductive years, especially against diseases such as tetanus, hepatitis B, measles, rubella and varicella. In addition to the recommended vaccines, in risk situations, inactivated vaccines could be administered to women who were not correctly vaccinated before, while attenuated vaccines are contraindicated.
Despite the fact that vaccination during pregnancy is a very important preventive measure and the existing recommendations from public health authorities, scientific societies and health professionals, the vaccination coverage could clearly be improved, especially against influenza and SARS-CoV-2, so any health professional involved in the care of pregnant women should proactively recommend these vaccines.
The Spanish Association of Pediatrics (AEP), through its Advisory Committee on Vaccines, and the Spanish Society of Gynaecology and Obstetrics (SEGO) recommend vaccination against the following diseases during pregnancy: against influenza and COVID-19, in any trimester of pregnancy and during the postpartum period (up to 6 months post birth) in women not vaccinated during pregnancy; against pertussis, with the Tdap vaccine, between weeks 27 and 36 of gestation (in the CAV-AEP recommendations, preferably between weeks 27 and 28); and against RSV, with RSVPreF, between weeks 24 and 36 of gestation, preferably between weeks 32 and 36.
Durante el embarazo, los cambios fisiológicos en la respuesta inmunitaria favorecen que las gestantes sean más susceptibles a infecciones graves, tanto para ellas como para el feto, recién nacido y lactante. Todas las mujeres deberían entrar en el período reproductivo con su calendario vacunal correctamente cumplimentado, sobre todo en lo que respecta a enfermedades como tétanos, hepatitis B, sarampión, rubeola y varicela. Además de las vacunas recomendadas, en situaciones de riesgo las vacunas inactivadas podrían ser administradas en aquellas mujeres que no estuvieran correctamente inmunizadas con anterioridad, mientras que las atenuadas están contraindicadas.
A pesar de que la vacunación durante el embarazo es una medida preventiva muy importante, y de las recomendaciones de autoridades sanitarias, sociedades científicas y profesionales sanitarios, las coberturas vacunales son claramente mejorables, especialmente en lo que respecta a gripe y COVID-19, por lo que todo profesional sanitario que atienda a la embarazada debe ser proactivo en aconsejarlas.
La Asociación Española de Pediatría, a través de su Comité Asesor de Vacunas, y la Sociedad Española de Ginecología y Obstetricia recomiendan las siguientes vacunaciones durante la gestación: frente a gripe y COVID-19, en cualquier trimestre del embarazo, y durante el puerperio (hasta los 6 meses) en aquellas que no hubieran sido vacunadas durante la gestación; frente a tosferina con Tdpa, entre las 27 y 36 semanas de gestación (el CAV-AEP da preferencia entre las 27 y 28 semanas); y frente al VRS con RSVPreF, entre las 24 y 36 semanas de gestación, de preferencia entre las 32 y 36 semanas.</description><identifier>ISSN: 2341-2879</identifier><identifier>EISSN: 2341-2879</identifier><identifier>DOI: 10.1016/j.anpede.2024.02.014</identifier><identifier>PMID: 38565447</identifier><language>eng</language><publisher>Spain: Elsevier España, S.L.U</publisher><subject>Embarazo ; Flu ; Gripe ; Pertussis ; Pregnancy ; RSV ; SARS-CoV-2 ; Tosferina ; Vaccination ; Vacunación ; VRS E</subject><ispartof>Anales de Pediatría, 2024-04, Vol.100 (4), p.268-274</ispartof><rights>2024 Asociación Española de Pediatría</rights><rights>Copyright © 2024 Asociación Española de Pediatría. Published by Elsevier España, S.L.U. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2024-3399a02ebd302252180fbb23a1ca05ab7d4d0cf2e24b615f48f0191e419286223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38565447$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Álvarez Aldeán, Javier</creatorcontrib><creatorcontrib>José Álvarez García, Francisco</creatorcontrib><creatorcontrib>de la Calle Fernández-Miranda, Maria</creatorcontrib><creatorcontrib>Figueras Falcón, Tatiana</creatorcontrib><creatorcontrib>Iofrío de Arce, Antonio</creatorcontrib><creatorcontrib>López Rojano, Marta</creatorcontrib><creatorcontrib>Rivero Calle, Irene</creatorcontrib><creatorcontrib>Suy Franch, Anna</creatorcontrib><title>Vaccination in pregnancy. Consensus document of the CAV-AEP and the SEGO</title><title>Anales de Pediatría</title><addtitle>An Pediatr (Engl Ed)</addtitle><description>During pregnancy, physiological changes in the immune response make pregnant women more susceptible to serious infection, increasing the risk for the mother as well as the foetus, newborn and infant. All women should be correctly and fully vaccinated as they enter their reproductive years, especially against diseases such as tetanus, hepatitis B, measles, rubella and varicella. In addition to the recommended vaccines, in risk situations, inactivated vaccines could be administered to women who were not correctly vaccinated before, while attenuated vaccines are contraindicated.
Despite the fact that vaccination during pregnancy is a very important preventive measure and the existing recommendations from public health authorities, scientific societies and health professionals, the vaccination coverage could clearly be improved, especially against influenza and SARS-CoV-2, so any health professional involved in the care of pregnant women should proactively recommend these vaccines.
The Spanish Association of Pediatrics (AEP), through its Advisory Committee on Vaccines, and the Spanish Society of Gynaecology and Obstetrics (SEGO) recommend vaccination against the following diseases during pregnancy: against influenza and COVID-19, in any trimester of pregnancy and during the postpartum period (up to 6 months post birth) in women not vaccinated during pregnancy; against pertussis, with the Tdap vaccine, between weeks 27 and 36 of gestation (in the CAV-AEP recommendations, preferably between weeks 27 and 28); and against RSV, with RSVPreF, between weeks 24 and 36 of gestation, preferably between weeks 32 and 36.
Durante el embarazo, los cambios fisiológicos en la respuesta inmunitaria favorecen que las gestantes sean más susceptibles a infecciones graves, tanto para ellas como para el feto, recién nacido y lactante. Todas las mujeres deberían entrar en el período reproductivo con su calendario vacunal correctamente cumplimentado, sobre todo en lo que respecta a enfermedades como tétanos, hepatitis B, sarampión, rubeola y varicela. Además de las vacunas recomendadas, en situaciones de riesgo las vacunas inactivadas podrían ser administradas en aquellas mujeres que no estuvieran correctamente inmunizadas con anterioridad, mientras que las atenuadas están contraindicadas.
A pesar de que la vacunación durante el embarazo es una medida preventiva muy importante, y de las recomendaciones de autoridades sanitarias, sociedades científicas y profesionales sanitarios, las coberturas vacunales son claramente mejorables, especialmente en lo que respecta a gripe y COVID-19, por lo que todo profesional sanitario que atienda a la embarazada debe ser proactivo en aconsejarlas.
La Asociación Española de Pediatría, a través de su Comité Asesor de Vacunas, y la Sociedad Española de Ginecología y Obstetricia recomiendan las siguientes vacunaciones durante la gestación: frente a gripe y COVID-19, en cualquier trimestre del embarazo, y durante el puerperio (hasta los 6 meses) en aquellas que no hubieran sido vacunadas durante la gestación; frente a tosferina con Tdpa, entre las 27 y 36 semanas de gestación (el CAV-AEP da preferencia entre las 27 y 28 semanas); y frente al VRS con RSVPreF, entre las 24 y 36 semanas de gestación, de preferencia entre las 32 y 36 semanas.</description><subject>Embarazo</subject><subject>Flu</subject><subject>Gripe</subject><subject>Pertussis</subject><subject>Pregnancy</subject><subject>RSV</subject><subject>SARS-CoV-2</subject><subject>Tosferina</subject><subject>Vaccination</subject><subject>Vacunación</subject><subject>VRS E</subject><issn>2341-2879</issn><issn>2341-2879</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kE9Lw0AQxRdRbFG_gUiOXhJnZzdpchFKqX-gUEHtddnsTnRLu6nZROi3N7VVPHmaGfi9mTePsUsOCQee3SwT7TdkKUFAmQAmwOURG6KQPMZ8VBz_6QfsIoQlAKDgIpXZKRuIPM1SKUdD9rDQxjivW1f7yPlo09Cb195sk2hS-0A-dCGytenW5NuorqL2naLJeBGPp0-R9vZ7fp7ez8_ZSaVXgS4O9Yy93k1fJg_xbH7_OBnPYrOzGgtRFBqQSisAMUWeQ1WWKDQ3GlJdjqy0YCoklGXG00rmFfCCk-QF5hmiOGPX-72bpv7oKLRq7YKh1Up7qrugBAieZThKsx6Ve9Q0dQgNVWrTuLVutoqD2sWolmofo9p5U4Cqj7GXXR0udOWa7K_oJ7QeuN0D1P_56ahRwTjyhqxryLTK1u7_C18uk4HJ</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>Álvarez Aldeán, Javier</creator><creator>José Álvarez García, Francisco</creator><creator>de la Calle Fernández-Miranda, Maria</creator><creator>Figueras Falcón, Tatiana</creator><creator>Iofrío de Arce, Antonio</creator><creator>López Rojano, Marta</creator><creator>Rivero Calle, Irene</creator><creator>Suy Franch, Anna</creator><general>Elsevier España, S.L.U</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202404</creationdate><title>Vaccination in pregnancy. Consensus document of the CAV-AEP and the SEGO</title><author>Álvarez Aldeán, Javier ; José Álvarez García, Francisco ; de la Calle Fernández-Miranda, Maria ; Figueras Falcón, Tatiana ; Iofrío de Arce, Antonio ; López Rojano, Marta ; Rivero Calle, Irene ; Suy Franch, Anna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2024-3399a02ebd302252180fbb23a1ca05ab7d4d0cf2e24b615f48f0191e419286223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Embarazo</topic><topic>Flu</topic><topic>Gripe</topic><topic>Pertussis</topic><topic>Pregnancy</topic><topic>RSV</topic><topic>SARS-CoV-2</topic><topic>Tosferina</topic><topic>Vaccination</topic><topic>Vacunación</topic><topic>VRS E</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Álvarez Aldeán, Javier</creatorcontrib><creatorcontrib>José Álvarez García, Francisco</creatorcontrib><creatorcontrib>de la Calle Fernández-Miranda, Maria</creatorcontrib><creatorcontrib>Figueras Falcón, Tatiana</creatorcontrib><creatorcontrib>Iofrío de Arce, Antonio</creatorcontrib><creatorcontrib>López Rojano, Marta</creatorcontrib><creatorcontrib>Rivero Calle, Irene</creatorcontrib><creatorcontrib>Suy Franch, Anna</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Anales de Pediatría</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Álvarez Aldeán, Javier</au><au>José Álvarez García, Francisco</au><au>de la Calle Fernández-Miranda, Maria</au><au>Figueras Falcón, Tatiana</au><au>Iofrío de Arce, Antonio</au><au>López Rojano, Marta</au><au>Rivero Calle, Irene</au><au>Suy Franch, Anna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vaccination in pregnancy. Consensus document of the CAV-AEP and the SEGO</atitle><jtitle>Anales de Pediatría</jtitle><addtitle>An Pediatr (Engl Ed)</addtitle><date>2024-04</date><risdate>2024</risdate><volume>100</volume><issue>4</issue><spage>268</spage><epage>274</epage><pages>268-274</pages><issn>2341-2879</issn><eissn>2341-2879</eissn><abstract>During pregnancy, physiological changes in the immune response make pregnant women more susceptible to serious infection, increasing the risk for the mother as well as the foetus, newborn and infant. All women should be correctly and fully vaccinated as they enter their reproductive years, especially against diseases such as tetanus, hepatitis B, measles, rubella and varicella. In addition to the recommended vaccines, in risk situations, inactivated vaccines could be administered to women who were not correctly vaccinated before, while attenuated vaccines are contraindicated.
Despite the fact that vaccination during pregnancy is a very important preventive measure and the existing recommendations from public health authorities, scientific societies and health professionals, the vaccination coverage could clearly be improved, especially against influenza and SARS-CoV-2, so any health professional involved in the care of pregnant women should proactively recommend these vaccines.
The Spanish Association of Pediatrics (AEP), through its Advisory Committee on Vaccines, and the Spanish Society of Gynaecology and Obstetrics (SEGO) recommend vaccination against the following diseases during pregnancy: against influenza and COVID-19, in any trimester of pregnancy and during the postpartum period (up to 6 months post birth) in women not vaccinated during pregnancy; against pertussis, with the Tdap vaccine, between weeks 27 and 36 of gestation (in the CAV-AEP recommendations, preferably between weeks 27 and 28); and against RSV, with RSVPreF, between weeks 24 and 36 of gestation, preferably between weeks 32 and 36.
Durante el embarazo, los cambios fisiológicos en la respuesta inmunitaria favorecen que las gestantes sean más susceptibles a infecciones graves, tanto para ellas como para el feto, recién nacido y lactante. Todas las mujeres deberían entrar en el período reproductivo con su calendario vacunal correctamente cumplimentado, sobre todo en lo que respecta a enfermedades como tétanos, hepatitis B, sarampión, rubeola y varicela. Además de las vacunas recomendadas, en situaciones de riesgo las vacunas inactivadas podrían ser administradas en aquellas mujeres que no estuvieran correctamente inmunizadas con anterioridad, mientras que las atenuadas están contraindicadas.
A pesar de que la vacunación durante el embarazo es una medida preventiva muy importante, y de las recomendaciones de autoridades sanitarias, sociedades científicas y profesionales sanitarios, las coberturas vacunales son claramente mejorables, especialmente en lo que respecta a gripe y COVID-19, por lo que todo profesional sanitario que atienda a la embarazada debe ser proactivo en aconsejarlas.
La Asociación Española de Pediatría, a través de su Comité Asesor de Vacunas, y la Sociedad Española de Ginecología y Obstetricia recomiendan las siguientes vacunaciones durante la gestación: frente a gripe y COVID-19, en cualquier trimestre del embarazo, y durante el puerperio (hasta los 6 meses) en aquellas que no hubieran sido vacunadas durante la gestación; frente a tosferina con Tdpa, entre las 27 y 36 semanas de gestación (el CAV-AEP da preferencia entre las 27 y 28 semanas); y frente al VRS con RSVPreF, entre las 24 y 36 semanas de gestación, de preferencia entre las 32 y 36 semanas.</abstract><cop>Spain</cop><pub>Elsevier España, S.L.U</pub><pmid>38565447</pmid><doi>10.1016/j.anpede.2024.02.014</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2341-2879 |
ispartof | Anales de Pediatría, 2024-04, Vol.100 (4), p.268-274 |
issn | 2341-2879 2341-2879 |
language | eng |
recordid | cdi_proquest_miscellaneous_3031662756 |
source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Embarazo Flu Gripe Pertussis Pregnancy RSV SARS-CoV-2 Tosferina Vaccination Vacunación VRS E |
title | Vaccination in pregnancy. Consensus document of the CAV-AEP and the SEGO |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T00%3A59%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vaccination%20in%20pregnancy.%20Consensus%20document%20of%20the%20CAV-AEP%20and%20the%20SEGO&rft.jtitle=Anales%20de%20Pediatr%C3%ADa&rft.au=%C3%81lvarez%20Alde%C3%A1n,%20Javier&rft.date=2024-04&rft.volume=100&rft.issue=4&rft.spage=268&rft.epage=274&rft.pages=268-274&rft.issn=2341-2879&rft.eissn=2341-2879&rft_id=info:doi/10.1016/j.anpede.2024.02.014&rft_dat=%3Cproquest_cross%3E3031662756%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3031662756&rft_id=info:pmid/38565447&rft_els_id=S2341287924001066&rfr_iscdi=true |